HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andrea Becciolini Selected Research

mavrilimumab

11/2019Targeting Granulocyte-Monocyte Colony-Stimulating Factor Signaling in Rheumatoid Arthritis: Future Prospects.
7/2019Mavrilimumab: a unique insight and update on the current status in the treatment of rheumatoid arthritis.
1/2017Spotlight on mavrilimumab for the treatment of rheumatoid arthritis: evidence to date.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Andrea Becciolini Research Topics

Disease

19Rheumatoid Arthritis
01/2022 - 04/2016
7Psoriatic Arthritis
10/2022 - 04/2016
4Ankylosing Spondylitis
01/2022 - 08/2017
3Fatigue
03/2021 - 01/2018
3Psoriasis (Pustulosis Palmaris et Plantaris)
03/2021 - 10/2017
3Inflammation (Inflammations)
11/2019 - 01/2015
3Pain (Aches)
11/2019 - 10/2015
2Arthritis (Polyarthritis)
02/2022 - 01/2017
2Rheumatic Diseases (Rheumatism)
02/2022 - 11/2019
2Axial Spondyloarthritis
12/2018 - 01/2017
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 04/2016
2Anterior Uveitis
01/2018 - 04/2016
2Knee Osteoarthritis
11/2015 - 10/2015
1Spondylarthritis (Spinal Arthritis)
02/2022
1Dyspnea (Shortness of Breath)
12/2021
1Chronic Disease (Chronic Diseases)
11/2019
1Osteoarthritis
11/2019
1Systemic Scleroderma (Systemic Sclerosis)
11/2019
1Giant Cell Arteritis (Horton Disease)
11/2019
1Anemia
01/2019
1Type 2 Diabetes Mellitus (MODY)
01/2019
1Fibromyalgia (Fibrositis)
05/2018
1Mood Disorders (Mood Disorder)
01/2018
1Spondylarthropathies
01/2018
1Uveitis
10/2017
1Juvenile Arthritis (Juvenile Idiopathic Arthritis)
08/2017
1Spondylitis
01/2017
1Latent Tuberculosis
04/2016
1Infections
04/2016
1Synovitis
01/2015
1Enthesopathy
07/2011

Drug/Important Bio-Agent (IBA)

8Biological ProductsIBA
12/2018 - 01/2015
7Adalimumab (Humira)FDA Link
02/2022 - 04/2016
7Etanercept (Enbrel)FDA Link
01/2022 - 04/2016
4Tumor Necrosis Factor InhibitorsIBA
02/2018 - 04/2016
3Pharmaceutical PreparationsIBA
01/2022 - 04/2016
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2019 - 01/2018
3mavrilimumabIBA
11/2019 - 01/2017
2Biosimilar PharmaceuticalsIBA
02/2022 - 01/2022
2ametantrone (HAQ)IBA
12/2021 - 03/2021
2Janus KinasesIBA
11/2019 - 01/2019
2tocilizumab (atlizumab)FDA Link
01/2019 - 04/2016
2CytokinesIBA
01/2018 - 01/2015
2Methotrexate (Mexate)FDA LinkGeneric
01/2018 - 09/2016
2sarilumabIBA
01/2018 - 01/2017
2Antirheumatic Agents (DMARD)IBA
12/2017 - 01/2015
2Ustekinumab (CNTO 1275)FDA Link
10/2017 - 04/2016
2Infliximab (Remicade)FDA Link
01/2017 - 04/2016
26- amino- 1- hydroxyhexane- 1,1- diphosphonateIBA
11/2015 - 10/2015
1apremilastIBA
10/2022
1ABP 501IBA
02/2022
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2019
1namilumabIBA
11/2019
1Colony-Stimulating Factors (Colony Stimulating Factor)IBA
11/2019
1Interleukin-6 (Interleukin 6)IBA
11/2019
1GLPG0634IBA
01/2019
1upadacitinibIBA
01/2019
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
05/2018
1golimumabFDA Link
02/2018
1HLA-B27 Antigen (HLA B27 Antigen)IBA
01/2018
1secukinumabIBA
10/2017
1CT-P13IBA
01/2017
1Monoclonal AntibodiesIBA
04/2016
1Biomarkers (Surrogate Marker)IBA
04/2016
1Abatacept (Orencia)FDA Link
04/2016
1AutoantibodiesIBA
01/2015
1C-Reactive ProteinIBA
07/2011
1Phosphorus (Red Phosphorus)IBA
07/2011
1Triglycerides (Triacylglycerol)IBA
07/2011
1CalciumIBA
07/2011
1Parathyroid Hormone (Parathormone)IBA
07/2011
1CholesterolIBA
07/2011

Therapy/Procedure

5Biological Therapy
12/2018 - 04/2016
2Therapeutics
01/2018 - 09/2016
1Peritoneal Dialysis
07/2011